Top

Published in:

Open Access 01-12-2021 | Long-COVID Syndrome | Study protocol

A randomised controlled trial testing the efficacy of Fit after COVID, a cognitive behavioural therapy targeting severe post-infectious fatigue following COVID-19 (ReCOVer): study protocol

Authors: T. A. Kuut, F. Müller, A. Aldenkamp, E. Assmann-Schuilwerve, A. Braamse, S. E. Geerlings, K. B. Gibney, R. A. A. Kanaan, P. Nieuwkerk, T. C. Olde Hartman, D. Pauëlsen, M. Prins, K. Slieker, M. Van Vugt, C. P. Bleeker-Rovers, S. P. Keijmel, H. Knoop

Published in: Trials | Issue 1/2021

Abstract

Background

Coronavirus disease 2019 (COVID-19) results in debilitating long-term symptoms, often referred to as Post-Acute Sequelae of SARS-CoV-2 Infection (PASC), in a substantial subgroup of patients. One of the most prevalent symptoms following COVID-19 is severe fatigue. Prompt delivery of cognitive behavioural therapy (CBT), an evidence-based treatment that has shown benefit in reducing severe fatigue in other conditions, may reduce post-COVID-19 fatigue. Based on an existing CBT protocol, a blended intervention of 17 weeks, Fit after COVID, was developed to treat severe fatigue after the acute phase of infection with SARS-CoV-2.

Method

The ReCOVer study is a multicentre 2-arm randomised controlled trial (RCT) to test the efficacy of Fit after COVID on severe post-infectious fatigue. Participants are eligible if they report severe fatigue 3 up to and including 12 months following COVID-19. One hundred and fourteen participants will be randomised to either Fit after COVID or care as usual (ratio 1:1). The primary outcome, the fatigue severity subscale of the Checklist Individual Strength (CIS-fatigue), is assessed in both groups before randomisation (T0), directly post CBT or following care as usual (T1), and at follow-up 6 months after the second assessment (T2). In addition, a long-term follow-up (T3), 12 months after the second assessment, is performed in the CBT group only. The primary objective is to investigate whether CBT will lead to a significantly lower mean fatigue severity score measured with the CIS-fatigue across the first two follow-up assessments (T1 and T2) as compared to care as usual. Secondary objectives are to determine the proportion of participants no longer being severely fatigued (operationalised in different ways) at T1 and T2 and to investigate changes in physical and social functioning, in the number and severity of somatic symptoms and in problems concentrating across T1 and T2.

Discussion

This is the first trial testing a cognitive behavioural intervention targeting severe fatigue after COVID-19. If Fit after COVID is effective in reducing fatigue severity following COVID-19, this intervention could contribute to alleviating the long-term health consequences of COVID-19 by relieving one of its most prevalent and distressing long-term symptoms.

Trial registration

Netherlands Trial Register NL8947. Registered on 14 October 2020.

Available only for authorised users

National Institute for Health and Care Excellence (NICE). COVID-19 rapid guideline: managing the long-term effects of COVID-19 [Internet]. 2021. [cited 2020 Dec 18]. Available from: https://www.nice.org.uk/guidance/ng188.

Bennett S, Tafuro J, Mayer J, Darlington D, Wong CW, Muntean EA, et al. Clinical features and outcomes of adults with coronavirus disease 2019: A systematic review and pooled analysis of the literature. Int J Clin Pract. 2021;75(3) https://doi.org/10.1111/ijcp.13725.

Hasani H, Mardi S, Shakerian S, Taherzadeh-Ghahfarokhi N, Mardi P. The Novel Coronavirus Disease (COVID-19): A PRISMA Systematic Review and Meta-Analysis of Clinical and Paraclinical Characteristics, vol. 2020: BioMed Research International. Hindawi Limited; 2020.

Zhu J, Zhong Z, Ji P, Li H, Li B, Pang J, et al. Clinicopathological characteristics of 8697 patients with COVID-19 in China: A meta-analysis. Fam Med Community Heal. 2020;8(2) https://doi.org/10.1136/fmch-2020-000406.

Grant MC, Geoghegan L, Arbyn M, Mohammed Z, McGuinness L, Clarke EL, et al. The prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARS-CoV-2; COVID-19): A systematic review and meta-analysis of 148 studies from 9 countries. PLoS One. 2020;15(6):e0234765 https://doi.org/10.1371/journal.pone.0234765.PubMedPubMedCentralCrossRef

Salamanna F, Veronesi F, Martini L, Landini MP, Fini M. Post-COVID-19 syndrome: the persistent symptoms at the post-viral stage of the disease. a systematic review of the current data. Front Med. 2021;8 https://doi.org/10.3389/fmed.2021.653516.

Rogers JP, Chesney E, Oliver D, Pollak TA, McGuire P, Fusar-Poli P, et al. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry. 2020;7(7):611–27 https://doi.org/10.1016/S2215-0366(20)30203-0.PubMedPubMedCentralCrossRef

Perrin R, Riste L, Hann M, Walther A, Mukherjee A, Heald A. Into the looking glass: Post-viral syndrome post COVID-19, vol. 144: Medical Hypotheses. Churchill Livingstone; 2020.

Islam MF, Cotler J, Jason LA. Post-viral fatigue and COVID-19: lessons from past epidemics. Fatigue Biomed Heal Behav. 2020;8(2):61–9 https://doi.org/10.1080/21641846.2020.1778227.CrossRef

10.

Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220–32 https://doi.org/10.1016/S0140-6736(20)32656-8.PubMedPubMedCentralCrossRef

11.

Simani L, Ramezani M, Darazam IA, Sagharichi M, Aalipour MA, Ghorbani F, et al. Prevalence and correlates of chronic fatigue syndrome and post-traumatic stress disorder after the outbreak of the COVID-19. J Neurovirol. 2021;27(1):154–9 https://doi.org/10.1007/s13365-021-00949-1.PubMedPubMedCentralCrossRef

12.

Goërtz YMJ, Van Herck M, Delbressine JM, Vaes AW, Meys R, Machado FVC, et al. Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? ERJ Open Res. 2020;6(4):00542–2020 https://doi.org/10.1183/23120541.00542-2020.PubMedPubMedCentralCrossRef

13.

Boscolo-Rizzo P, Guida F, Polesel J, Marcuzzo AV, Capriotti V, D’Alessandro A, et al. Sequelae in adults at 12 months after mild-to-moderate coronavirus disease 2019 (COVID-19). Int Forum Allergy Rhinol. 2021:1–4 https://doi.org/10.1002/alr.22832. Available from: http://www.ncbi.nlm.nih.gov/pubmed/34109765.

14.

Moldofsky H, Patcai J. Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study. BMC Neurol. 2011;11(1) https://doi.org/10.1186/1471-2377-11-37.

15.

Lam MHB, Wing YK, Yu MWM, Leung CM, Ma RCW, Kong APS, et al. Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors long-term follow-up. Arch Intern Med. 2009;169(22):2142–7 Available from: https://jamanetwork.com/. https://doi.org/10.1001/archinternmed.2009.384.PubMedCrossRef

16.

Morroy G, Keijmel SP, Delsing CE, Bleijenberg G, Langendam M, Timen A, et al. Fatigue following acute Q-fever: A systematic literature review, vol. 11: PLoS ONE. Public Library of Science; 2016.

17.

Dong J, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020;20(5):533–4 ISSN 1473-3099, https://doi.org/10.1016/S1473-3099(20)30120-1. https://www.sciencedirect.com/science/article/pii/S1473309920301201.PubMedPubMedCentralCrossRef

18.

Hulme K, Hudson JL, Rojczyk P, Little P, Moss-Morris R. Biopsychosocial risk factors of persistent fatigue after acute infection: a systematic review to inform interventions. J Psychosom Res. 2017;99:120–9.PubMedCrossRef

19.

Korenromp IHE, Meeus M, Bleijenberg G. Nederlandstalige definitie van chronische vermoeidheid. [Dutch language area definition of chronic fatigue]. Ned Tijdschr Geneeskd. 2012;156(A44003):1–2.

20.

Nakatomi Y, Mizuno K, Ishii A, Wada Y, Tanaka M, Tazawa S, et al. Neuroinflammation in patients with chronic fatigue syndrome/myalgic encephalomyelitis: An11C-(R)-PK11195 PET study. J Nucl Med. 2014;55(6):945–50 https://doi.org/10.2967/jnumed.113.131045.PubMedCrossRef

21.

Rasa S, Nora-Krukle Z, Henning N, Eliassen E, Shikova E, Harrer T, et al. Chronic viral infections in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), vol. 16: Journal of Translational Medicine. BioMed Central Ltd; 2018.

22.

Keijmel SP, Saxe J, van der Meer JWM, Nikolaus S, Netea MG, Bleijenberg G, et al. A comparison of patients with Q fever fatigue syndrome and patients with chronic fatigue syndrome with a focus on inflammatory markers and possible fatigue perpetuating cognitions and behaviour. J Psychosom Res. 2015;79(4):295–302 https://doi.org/10.1016/j.jpsychores.2015.07.005.PubMedCrossRef

23.

Menting J, Tack CJ, Donders R, Knoop H. Potential Mechanisms Involved in the Effect of Cognitive Behavioral Therapy on Fatigue Severity in Type 1 Diabetes. J Consult Clin Psychol. 2018;86(4):330–40 https://doi.org/10.1037/ccp0000290.PubMedCrossRef

24.

Menting J, Tack CJ, Bleijenberg G, Donders R, Fortuyn HAD, Fransen J, et al. Is fatigue a disease-specific or generic symptom in chronic medical conditions? Heal Psychol. 2018;37(6):530–43 https://doi.org/10.1037/hea0000598.CrossRef

25.

Wiborg JF, Knoop H, Frank LE, Bleijenberg G. Towards an evidence-based treatment model for cognitive behavioral interventions focusing on chronic fatigue syndrome. J Psychosom Res. 2012;72(5):399–404.PubMedCrossRef

26.

Keijmel SP, Delsing CE, Bleijenberg G, Van Der Meer JWM, Donders RT, Leclercq M, et al. Effectiveness of long-term doxycycline treatment and cognitive-behavioral therapy on fatigue severity in patients with Q Fever Fatigue Syndrome (Qure Study): A randomized controlled trial. Clin Infect Dis. 2017;64(8):998–1005 https://doi.org/10.1093/cid/cix013.PubMedCrossRef

27.

Abrahams HJG, Gielissen MFM, Donders RRT, Goedendorp MM, van der Wouw AJ, Verhagen CAHHVM, et al. The efficacy of Internet-based cognitive behavioral therapy for severely fatigued survivors of breast cancer compared with care as usual: A randomized controlled trial. Cancer. 2017;123(19):3825–34 https://doi.org/10.1002/cncr.30815.PubMedCrossRef

28.

Castell BD, Kazantzis N, Moss-Morris RE. Cognitive behavioral therapy and graded exercise for chronic fatigue syndrome: a meta-analysis. Clin Psychol Sci Pr. 2011;18(4):311–24 https://doi.org/10.1111/j.1468-2850.2011.01262.x.CrossRef

29.

Janse A, Worm-Smeitink M, Bleijenberg G, Donders R, Knoop H. Efficacy of web-based cognitive-behavioural therapy for chronic fatigue syndrome: Randomised controlled trial. Br J Psychiatry. 2018;212(2):112–8 https://doi.org/10.1192/bjp.2017.22.PubMedCrossRef

30.

Menting J, Tack CJ, van Bon AC, Jansen HJ, van den Bergh JP, Mol MJTM, et al. Web-based cognitive behavioural therapy blended with face-to-face sessions for chronic fatigue in type 1 diabetes: a multicentre randomised controlled trial. Lancet Diabetes Endocrinol. 2017;5(6):448–56 https://doi.org/10.1016/S2213-8587(17)30098-0.PubMedCrossRef

31.

Knoop H, Van Der Meer JWM, Bleijenberg G. Guided self-instructions for people with chronic fatigue syndrome: Randomised controlled trial. Br J Psychiatry. 2008;193(4):340–1 https://doi.org/10.1192/bjp.bp.108.051292.PubMedCrossRef

32.

Sharpe M, Goldsmith KA, Johnson AL, Chalder T, Walker J, White PD. Rehabilitative treatments for chronic fatigue syndrome: long-term follow-up from the PACE trial. Lancet Psychiatry. 2015;2(12):1067–74 https://doi.org/10.1016/S2215-0366(15)00317-X. Epub 2015 Oct 28. PMID: 26521770.PubMedCrossRef

33.

Janse A, Nikolaus S, Wiborg JF, Heins M, van der Meer JWM, Bleijenberg G, et al. Long-term follow-up after cognitive behaviour therapy for chronic fatigue syndrome. J Psychosom Res. 2017;97:45–51 https://doi.org/10.1016/j.jpsychores.2017.03.016.PubMedCrossRef

34.

Raijmakers RPH, Keijmel SP, Breukers EMC, Bleijenberg G, van der Meer JWM, Bleeker-Rovers CP, et al. Long-term effect of cognitive behavioural therapy and doxycycline treatment for patients with Q fever fatigue syndrome: One-year follow-up of the Qure study. J Psychosom Res. 2019;116:62–7 https://doi.org/10.1016/j.jpsychores.2018.11.007.PubMedCrossRef

35.

Van Gessel LD, Abrahams HJG, Prinsen H, Bleijenberg G, Heins M, Twisk J, et al. Are the effects of cognitive behavior therapy for severe fatigue in cancer survivors sustained up to 14 years after therapy? J Cancer Surviv. 2018;12(4):519–27 https://doi.org/10.1007/s11764-018-0690-z.PubMedCrossRef

36.

Janse A, Bleijenberg G, Knoop H. Prediction of long-term outcome after cognitive behavioral therapy for chronic fatigue syndrome. J Psychosom Res. 2019;121:93–9 https://doi.org/10.1016/j.jpsychores.2019.03.017.PubMedCrossRef

37.

Moss-Morris R, Spence MJ, Hou R. The pathway from glandular fever to chronic fatigue syndrome: Can the cognitive behavioural model provide the map? Psychol Med. 2011;41(5):1099–107 https://doi.org/10.1017/S003329171000139X.PubMedCrossRef

38.

Worm-Smeitink M, Gielissen M, Bloot L, van Laarhoven HWM, van Engelen BGM, van Riel P, et al. The assessment of fatigue: Psychometric qualities and norms for the Checklist individual strength. J Psychosom Res. 2017;98:40–6 https://doi.org/10.1016/j.jpsychores.2017.05.007.PubMedCrossRef

39.

Chan AW, Tetzlaff JM, Gøtzsche PC, Altman DG, Mann H, Berlin JA, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013;346(jan08 15) https://doi.org/10.1136/bmj.e7586.

40.

Aaronson NK, Muller M, PDA C, Essink-Bot M-L, Fekkes M, Sanderman R, et al. Translation, validation, and norming of the dutch language version of the SF-36 health survey in community and chronic disease populations. J Clin Epidemiol. 1998;51(11):1055–68.PubMedCrossRef

41.

Thandi G, Fear NT, Chalder T. A comparison of the Work and Social Adjustment Scale (WSAS) across different patient populations using Rasch analysis and exploratory factor analysis. J Psychosom Res. 2017;92:45–8 https://doi.org/10.1016/j.jpsychores.2016.11.009.PubMedCrossRef

42.

Weathers FW, Litz BT, Keane TM, Palmieri PA, Marx BP, Schnurr PP. The PTSD Checklist for DSM-5 (PCL-5). Scale available from the National Center for PTSD at www.ptsd.va.gov. 2013.

43.

Steer RA, Cavalieri TA, Leonard DM, Beck AT. Use of the Beck Depression Inventory for Primary Care to Screen for Major Depression Disorders. Gen Hosp Psychiatry. 1999;21(2):106–11 https://doi.org/10.1016/S0163-8343(98)00070-X.PubMedCrossRef

44.

Beck AT, Guth D, Steew RA, Ball R. Screening for major depression disorders in medical inpatients with the beck depression inventory for primary care. Behav Res Ther. 1997;35(8):785–91 https://doi.org/10.1016/S0005-7967(97)00025-9.PubMedCrossRef

45.

Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(Suppl 20):22–33.PubMed

46.

Knoop H, Blijenberg G. Het chronisch vermoeidheidssyndroom: behandelprotocol cognitieve gedragstherapie voor cvs. Houten: Bohn Stafleu van Loghum; 2010.

47.

Abrahams HJG, Gielissen MFM, Goedendorp MM, Berends T, Peters MEWJ, Poort H, et al. A randomized controlled trial of web-based cognitive behavioral therapy for severely fatigued breast cancer survivors (CHANGE-study): Study protocol. BMC Cancer. 2015;15(1) https://doi.org/10.1186/s12885-015-1787-7.

48.

Morin CM, Belleville G, Bélanger L, Ivers H. The Insomnia Severity Index: psychometric indicators to detect insomnia cases and evaluate treatment response. Sleep. 2011;34(5):601–8 https://doi.org/10.1093/sleep/34.5.601.PubMedPubMedCentralCrossRef

49.

Jacobsen PB, Andrykowski MA, Thors CL. Relationship of Catastrophizing to Fatigue among Women Receiving Treatment for Breast Cancer. J Consult Clin Psychol. 2004;72(2):355–61 https://doi.org/10.1037/0022-006X.72.2.355.PubMedPubMedCentralCrossRef

50.

Ray C, Weir W, Stewart D, Miller P, Hyde G. Ways of coping with Chronic Fatigue Syndrome: Development of an illness management questionnaire. Soc Sci Med. 1993;37(3):385–91 https://doi.org/10.1016/0277-9536(93)90268-9.PubMedCrossRef

51.

Heins MJ, Knoop H, Burk WJ, Bleijenberg G. The process of cognitive behaviour therapy for chronic fatigue syndrome: Which changes in perpetuating cognitions and behaviour are related to a reduction in fatigue? J Psychosom Res. 2013;75(3):235–41 https://doi.org/10.1016/j.jpsychores.2013.06.034.PubMedCrossRef

52.

Prins JB, Bleijenberg G, Bazelmans E, Elving LD, De Boo TM, Severens JL, et al. Cognitive behaviour therapy for chronic fatigue syndrome: A multicentre randomised controlled trial. Lancet. 2001;357(9259):841–7 https://doi.org/10.1016/S0140-6736(00)04198-2.PubMedCrossRef

53.

Van Der Werf SP, Prins JB, Vercoulen JHMM, Van Der Meer JWM, Bleijenberg G. Identifying physical activity patterns in chronic fatigue syndrome using actigraphic assessment. J Psychosom Res. 2000;49(5):373–9 https://doi.org/10.1016/S0022-3999(00)00197-5.PubMedCrossRef

54.

Bridges KR, Sanderman R, Van Sonderen E. An English language version of the social support list: Preliminary reliability. Psychol Rep. 2002;90(3 PART 1):1055–8.PubMedCrossRef

55.

van Sonderen E. Het meten van sociale steun met de Sociale Steun Lijst-Interacties (SSL-I) en Sociale Steun Lijst-Discrepanties (SSL-D): een handleiding. 2 e dr. Groningen; 2012.

56.

van der Ploeg E, Mooren TTM, Kleber RJ, van der Velden PG, Brom D. Construct Validation of the Dutch Version of the Impact of Event Scale. Psychol Assess. 2004;16(1).

57.

Vanaken L, Scheveneels S, Belmans E, Hermans D. Validation of the Impact of Event Scale With Modifications for COVID-19 (IES-COVID19). Front Psychiatry. 2020;11 https://doi.org/10.3389/fpsyt.2020.00738.

58.

Custers JAE, van den Berg SW, van Laarhoven HWM, Bleiker EMA, Gielissen MFM, Prins JB. The cancer worry scale. Cancer Nurs. 2014;37(1):E44–50.PubMedCrossRef

59.

Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54(7):581–6 https://doi.org/10.1136/thx.54.7.581.PubMedPubMedCentralCrossRef

60.

Castor Electronic Data Capture. [online] Available at: https://castoredc.com. Castor EDC. 2019.

61.

Vercoulen JHMM, Swanink CMA, Fennis JFM, Galama JMD, van der Meer JWM, Bleijenberg G. Dimensional assessment of chronic fatigue syndrome. J Psychosom Res. 1994;38(5):383–92 https://doi.org/10.1016/0022-3999(94)90099-X.PubMedCrossRef

62.

Dittner AJ, Wessely SC, Brown RG. The assessment of fatigue: A practical guide for clinicians and researchers. J Psychosom Res. 2004;56(2):157–70 https://doi.org/10.1016/S0022-3999(03)00371-4.PubMedCrossRef

63.

Wiborg JF, Van Bussel J, Van Dijk A, Bleijenberg G, Knoop H. Randomised Controlled Trial of Cognitive Behaviour Therapy Delivered in Groups of Patients with Chronic Fatigue Syndrome. Psychother Psychosom. 2015;84(6):368–76 https://doi.org/10.1159/000438867.PubMedCrossRef

64.

Stewart AL, Hays RD, Ware JE. The MOS short-form general health survey. Med Care. 1988;26(7).

65.

Mundt JC, Marks IM, Shear MK, Greist JH. The Work and Social Adjustment Scale: a simple measure of impairment in functioning. Br J Psychiatry. 2002;180(5):461–4 https://doi.org/10.1192/bjp.180.5.461.PubMedCrossRef

66.

Kroenke K, Spitzer RL, Williams JBW. The PHQ-15: Validity of a New Measure for Evaluating the Severity of Somatic Symptoms [Internet]. 2002. Available from: http://journals.lww.com/psychosomaticmedicine.

67.

Migueles JH, Rowlands AV, Huber F, Sabia S, van Hees VT. GGIR: a research community–driven open source R package for generating physical activity and sleep outcomes from multi-day raw accelerometer data. J Meas Phys Behav. 2019;2(3):188–96 https://doi.org/10.1123/jmpb.2018-0063.CrossRef

68.

Buysse DJ, Ancoli-Israel S, Edinger JD, Lichstein KL, Morin CM. Recommendations for a standard research assessment of insomnia. Sleep. 2006;29(9):1155–73 https://doi.org/10.1093/sleep/29.9.1155.PubMedCrossRef

69.

Carney CE, Buysse DJ, Ancoli-Israel S, Edinger JD, Krystal AD, Lichstein KL, et al. The consensus sleep diary: Standardizing prospective sleep self-monitoring. Sleep. 2012;35:287–302.PubMedPubMedCentralCrossRef

70.

Bergner M, Bobbitt RA, Carter WB, Gilson BS. The Sickness Impact Profile: Development and Final Revision of a Health Status Measure. Care. 1981;19(8):787–805 https://doi.org/10.1097/00005650-198108000-00001.CrossRef

71.

Jacobs HM, Luttik A, De T-OF, Melker RA. The sickness impactprofile; results of an evaluation study of the Dutch version. Ned TijdschrGeneeskd. 1990;134(40):150–4.

72.

Reeves WC, Lloyd A, Vernon SD, Klimas N, Jason LA, Bleijenberg G, et al. Identification of ambiguities in the 1994 chronic fatigue syndrome research case definition and recommendations for resolution [Internet]. BMC Health Serv Res. 2003; Available from: http://www.who.int/msa/cidi/listofcon;3(1). https://doi.org/10.1186/1472-6963-3-25.

73.

Kroenke K, Spitzer RL, Williams JBW, Löwe B. The patient health questionnaire somatic, anxiety, and depressive symptom scales: a systematic review. Gen Hosp Psychiatry. 2010;32(4):345–59 https://doi.org/10.1016/j.genhosppsych.2010.03.006.PubMedCrossRef

74.

Broadbent E, Petrie KJ, Main J, Weinman J. The Brief Illness Perception Questionnaire. J Psychosom Res. 2006;60(6):631–7 https://doi.org/10.1016/j.jpsychores.2005.10.020.PubMedCrossRef

75.

de Raaij EJ, Schröder C, Maissan FJ, Pool JJ, Wittink H. Cross-cultural adaptation and measurement properties of the Brief Illness Perception Questionnaire-Dutch Language Version. Man Ther. 2012;17(4):330–5 https://doi.org/10.1016/j.math.2012.03.001.PubMedCrossRef

76.

Vercoulen JHMM, Swanink CMA, Galama JMD, Fennis JFM, Jongen PJH, Hommes OR, et al. The persistence of fatigue in chronic fatigue syndrome and multiple sclerosis: development of a model. J Psychosom Res. 1998;45(6):507–17 https://doi.org/10.1016/S0022-3999(98)00023-3.PubMedCrossRef

77.

Dennison L, Moss-Morris R, Silber E, Galea I, Chalder T. Cognitive and behavioural correlates of different domains of psychological adjustment in early-stage multiple sclerosis. J Psychosom Res. 2010;69(4):353–61 https://doi.org/10.1016/j.jpsychores.2010.04.009.PubMedCrossRef

78.

Knoop H, Van Kessel K, Moss-Morris R. Which cognitions and behaviours mediate the positive effect of cognitive behavioural therapy on fatigue in patients with multiple sclerosis? Psychol Med. 2012;42(1):205–13 https://doi.org/10.1017/S0033291711000924.PubMedCrossRef

79.

Nijs J, De Meirleir K, Duquet W. Kinesiophobia in chronic fatigue syndrome: Assessment and associations with disability. Arch Phys Med Rehabil. 2004;85(10).

80.

Kool MB, van Middendorp H, Lumley MA, Schenk Y, Jacobs JW, Bijlsma JW, et al. Lack of understanding in fibromyalgia and rheumatoid arthritis: The Illness Invalidation Inventory (3*I). Ann Rheum Dis. 2010;69(11):1990–5 https://doi.org/10.1136/ard.2009.123224.PubMedCrossRef

81.

Smith BW, Dalen J, Wiggins K, Tooley E, Christopher P, Bernard J. The brief resilience scale: Assessing the ability to bounce back. Int J Behav Med. 2008;15(3):194–200 https://doi.org/10.1080/10705500802222972.PubMedCrossRef

82.

Consten C. Measuring Resilience with the Brief Resilience Scale: Factor Structure, Reliability and Validity of the Dutch Version of the BRS (BRSnl). The Netherlands: Enschede; 2016.

83.

Heins MJ, Knoop H, Bleijenberg G. The role of the therapeutic relationship in cognitive behaviour therapy for chronic fatigue syndrome. Behav Res Ther. 2013;51(7):368–76 https://doi.org/10.1016/j.brat.2013.02.001.PubMedCrossRef

84.

Jacobson NS, Truax P. Clinical Significance: A Statistical Approach to Defining Meaningful Change in Psychotherapy Research. J Consult Clin Psychol. 1991;59(1):12–9 https://doi.org/10.1037/0022-006X.59.1.12.PubMedCrossRef

85.

NFU: Richtlijn kwaliteitsborging mensgebonden onderzoek 2019. Nederlandse Federatie van Universitair Medische Centra. 2019.

86.

Morley S, Dowzer CN. Manual for the Leeds Reliable Change Indicator: Simple Excel applications for the analysis of individual patient and group data. University of Leeds, Leeds, UK. Leeds: University of Leeds; 2014. p. 1–13.

87.

Cohen J. A Power Primer. Psychol Biulletin. 1992;112(1):155–9 https://doi.org/10.1037/0033-2909.112.1.155.CrossRef

88.

Jim HSL, Hyland KA, Nelson AM, Pinilla-Ibarz J, Sweet K, Gielissen M, et al. Internet-assisted cognitive behavioral intervention for targeted therapy–related fatigue in chronic myeloid leukemia: Results from a pilot randomized trial. Cancer. 2020;126(1):174–80 https://doi.org/10.1002/cncr.32521.PubMedCrossRef

89.

Okkersen K, Jimenez-Moreno C, Wenninger S, Daidj F, Glennon J, Cumming S, et al. Cognitive behavioural therapy with optional graded exercise therapy in patients with severe fatigue with myotonic dystrophy type 1: a multicentre, single-blind, randomised trial. Lancet Neurol. 2018;17(8):671–80 https://doi.org/10.1016/S1474-4422(18)30203-5.PubMedCrossRef

90.

Jason LA, Mcmanimen S, Sunnquist M, Brown A, Newton JL, Strand EB. Examining the Institute of Medicine’s Recommendations Regarding Chronic Fatigue Syndrome: Clinical Versus Research Criteria HHS Public Access. J Neurol Psychol. 2015.

91.

Larun L, Brurberg KG, Odgaard-Jensen J, Price JR. Exercise therapy for chronic fatigue syndrome. Cochrane Database Syst Rev. 2019;2021(3).

92.

Buffart LM, Kalter J, Sweegers MG, Courneya KS, Newton RU, Aaronson NK, et al. Effects and moderators of exercise on quality of life and physical function in patients with cancer: An individual patient data meta-analysis of 34 RCTs. Cancer Treat Rev. 2017;52:91–104.PubMedCrossRef

93.

Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re’em Y, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019 ISSN 2589-5370, https://doi.org/10.1016/j.eclinm.2021.101019. Available from: https://linkinghub.elsevier.com/retrieve/pii/S2589537021002996.PubMedPubMedCentralCrossRef

Title: A randomised controlled trial testing the efficacy of Fit after COVID, a cognitive behavioural therapy targeting severe post-infectious fatigue following COVID-19 (ReCOVer): study protocol
Authors: T. A. Kuut
F. Müller
A. Aldenkamp
E. Assmann-Schuilwerve
A. Braamse
S. E. Geerlings
K. B. Gibney
R. A. A. Kanaan
P. Nieuwkerk
T. C. Olde Hartman
D. Pauëlsen
M. Prins
K. Slieker
M. Van Vugt
C. P. Bleeker-Rovers
S. P. Keijmel
H. Knoop
Publication date: 01-12-2021
Publisher: BioMed Central
Keywords: Long-COVID Syndrome
Behavioural Therapy
SARS-CoV-2
COVID-19
Fatigue
Published in: Trials / Issue 1/2021
Electronic ISSN: 1745-6215
DOI: https://doi.org/10.1186/s13063-021-05569-y

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

A randomised controlled trial testing the efficacy of Fit after COVID, a cognitive behavioural therapy targeting severe post-infectious fatigue following COVID-19 (ReCOVer): study protocol

Abstract

Background

Method

Discussion

Trial registration

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Method

Discussion

Trial registration

Please log in to get access to this content

Other articles of this Issue 1/2021

Use of probiotics to reduce infections and death and prevent colonization with extended-spectrum beta-lactamase (ESBL)-producing bacteria among newborn infants in Tanzania (ProRIDE Trial): study protocol for a randomized controlled clinical trial

Can we decrease the duration of basal thumb joint distraction for early osteoarthritis from 8 to 6 weeks? Study protocol for a non-inferiority randomized controlled trial

Recovering arm function in chronic stroke patients using combined anodal HD-tDCS and virtual reality therapy (ReArm): a study protocol for a randomized controlled trial

Safety and efficacy of Ayurvedic interventions and Yoga on long term effects of COVID-19: A structured summary of a study protocol for a randomized controlled trial

Correction to: Establishing a core outcome set for mucopolysaccharidoses (MPS) in children: study protocol for a rapid literature review, candidate outcomes survey, and Delphi surveys

The effect of in-person and virtual prenatal care education of the spouses of primiparous women on the father and mother’s attachment to infant: a quasi-experimental and controlled study